Olpasiran lowering of lipoprotein(a) according to baseline levels: insights from the OCEAN(a)-DOSE study.
Kaur G, Rosenson RS, Gencer B, López JAG, Lepor NE, Baum SJ, Stout E, Gaudet D, Knusel B, Park JG, Wang H, Wu Y, Kassahun H, Sabatine MS, O'Donoghue ML.
Kaur G, et al. Among authors: park jg.
Eur Heart J. 2024 Nov 20:ehae781. doi: 10.1093/eurheartj/ehae781. Online ahead of print.
Eur Heart J. 2024.
PMID: 39565305
No abstract available.